Perbedaan Organon Pharma Indonesia Tbk. dan Unilever Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Unilever Indonesia Tbk. diperdagangkan di Rp1.630 (kapitalisasi pasar 63,14 T, volume 24 jam 16,73 jt). Perbedaan utamanya: Unilever Indonesia Tbk. jauh lebih besar — sekitar 604,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | UNVR | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 63,14 T |
Volume | — | 16,73 jt |
Lot | — | 167,33 rb |
Perputaran | — | 27,33 M |
Harga Rata-rata | — | 1.633,14 |
Nilai Transaksi | — | 27,33 M |
Harga Ekuilibrium Indikatif | — | 1.630 |
Volume Ekuilibrium Indikatif | — | 6,97 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Selengkapnya di halaman UNVR →